Latest Financial Disclosure News

Boss Energy’s Alta Mesa Uranium Project in Texas is accelerating production with uranium extraction rates surpassing 3,000 pounds per day and ongoing wellfield expansion.

DTI Group has successfully closed a fully underwritten entitlement offer, raising $2.69 million to support its transit technology ambitions. The offer saw strong shareholder participation alongside a managed shortfall placement.

Wellnex Limited has withdrawn its recent announcement referencing a SP Angel research report containing forward-looking financial information, clarifying it does not endorse the projections.

The ASX has challenged Wellnex Life Limited over its recent shareholder announcement featuring forward-looking financial forecasts from SP Angel, prompting a mandated retraction due to disclosure shortcomings.

Champion Iron Limited reported record quarterly sales and strong earnings in FY2025 Q4, while advancing its DRPF project on schedule and declaring its eighth consecutive dividend.

Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.

Straker Ltd reports a solid FY25 performance marked by a strategic shift from legacy translation services to AI-powered language verification, underpinned by robust cash reserves and improved profitability.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

Capstone 510 Copper Georgia Corp. has amended its revolving credit facility, increasing its size to $1 billion and extending the maturity date to May 2029, enhancing its financial flexibility for ongoing projects.

Sigma Healthcare has released its standalone annual and sustainability reports for the year ending January 2025, marking the final disclosures before its merger with Chemist Warehouse Group in February 2025.

DTI Group Ltd has announced a fully underwritten non-renounceable entitlement offer to raise approximately $2.69 million by issuing new shares at a discounted price of $0.006 each. The offer, backed by major shareholder Finico Pty Ltd, aims to strengthen the company’s balance sheet and repay existing debt.

Universal Biosensors reported a 6% increase in revenue for Q1 2025 but posted a net loss of A$3.84 million, with cash reserves sufficient only through Q3 2025, raising questions about its financial sustainability.